These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28465341)

  • 1. Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis.
    Gorini F; Azzimonti L; Delfanti G; Scarfò L; Scielzo C; Bertilaccio MT; Ranghetti P; Gulino A; Doglioni C; Di Napoli A; Capri M; Franceschi C; Caligaris-Cappio F; Ghia P; Bellone M; Dellabona P; Casorati G; de Lalla C
    Blood; 2017 Jun; 129(26):3440-3451. PubMed ID: 28465341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cd1d regulates B cell development but not B cell accumulation and IL10 production in mice with pathologic CD5(+) B cell expansion.
    Palmer VL; Nganga VK; Rothermund ME; Perry GA; Swanson PC
    BMC Immunol; 2015 Nov; 16():66. PubMed ID: 26537916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid induction of CD1d expression primes chronic lymphocytic leukemia B cells for killing by CD8
    Ghnewa YG; O'Reilly VP; Vandenberghe E; Browne PV; McElligott AM; Doherty DG
    Clin Immunol; 2017 Oct; 183():91-98. PubMed ID: 28780376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.
    Zaborsky N; Gassner FJ; Asslaber D; Reinthaler P; Denk U; Flenady S; Hofbauer JP; Danner B; Rebhandl S; Harrer A; Geisberger R; Greil R; Egle A
    Oncotarget; 2016 Aug; 7(31):49459-49469. PubMed ID: 27385215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d-independent manner.
    Aoki T; Takami M; Takatani T; Motoyoshi K; Ishii A; Hara A; Toyoda T; Okada R; Hino M; Koyama-Nasu R; Kiuchi M; Hirahara K; Kimura MY; Nakayama T; Shimojo N; Motohashi S
    Cancer Sci; 2020 Jul; 111(7):2223-2233. PubMed ID: 32324315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced frequency of NKT-like cells in patients with progressive chronic lymphocytic leukemia.
    Jadidi-Niaragh F; Jeddi-Tehrani M; Ansaripour B; Razavi SM; Sharifian RA; Shokri F
    Med Oncol; 2012 Dec; 29(5):3561-9. PubMed ID: 22669567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
    Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
    Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting.
    Rotolo A; Caputo VS; Holubova M; Baxan N; Dubois O; Chaudhry MS; Xiao X; Goudevenou K; Pitcher DS; Petevi K; Kachramanoglou C; Iles S; Naresh K; Maher J; Karadimitris A
    Cancer Cell; 2018 Oct; 34(4):596-610.e11. PubMed ID: 30300581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A locus on mouse chromosome 13 inversely regulates CD1d expression and the development of invariant natural killer T-cells.
    Tsaih SW; Presa M; Khaja S; Ciecko AE; Serreze DV; Chen YG
    Genes Immun; 2015; 16(3):221-30. PubMed ID: 25654212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
    Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
    Front Immunol; 2018; 9():1266. PubMed ID: 29928278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.
    Weinkove R; Brooks CR; Carter JM; Hermans IF; Ronchese F
    Haematologica; 2013 Mar; 98(3):376-84. PubMed ID: 23065503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated Hepatic CD1d Levels Coincide with Invariant NKT Cell Defects in Chronic Hepatitis B Virus Infection.
    Tan X; Ding Y; Zhu P; Dou R; Liang Z; Yang D; Huang Z; Wang W; Wu X; Weng X
    J Immunol; 2018 May; 200(10):3530-3538. PubMed ID: 29643189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bispecific Single-Domain Antibody Boosts Autologous Vγ9Vδ2-T Cell Responses Toward CD1d in Chronic Lymphocytic Leukemia.
    de Weerdt I; Lameris R; Ruben JM; de Boer R; Kloosterman J; King LA; Levin MD; Parren PWHI; de Gruijl TD; Kater AP; van der Vliet HJ
    Clin Cancer Res; 2021 Mar; 27(6):1744-1755. PubMed ID: 33451981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular IL-4 and IFN-γ expression in iNKT cells from patients with chronic lymphocytic leukemia.
    Bojarska-Junak A; Waldowska M; Woś J; Chocholska S; Hus I; Tomczak W; Dzik M; Hus M; Roliński J
    Oncol Lett; 2018 Feb; 15(2):1580-1590. PubMed ID: 29434853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote
    Jahnke S; Schmid H; Secker KA; Einhaus J; Duerr-Stoerzer S; Keppeler H; Schober-Melms I; Baur R; Schumm M; Handgretinger R; Bethge W; Kanz L; Schneidawind C; Schneidawind D
    Front Immunol; 2019; 10():1542. PubMed ID: 31354710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing porcine invariant natural killer T cells: A comparative study with NK cells and T cells.
    Yang G; Artiaga BL; Lewis ST; Driver JP
    Dev Comp Immunol; 2017 Nov; 76():343-351. PubMed ID: 28694168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.
    Hayworth JL; Mazzuca DM; Maleki Vareki S; Welch I; McCormick JK; Haeryfar SM
    Immunol Cell Biol; 2012 Aug; 90(7):699-709. PubMed ID: 22041925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immune control of EBV-infected B cells by invariant natural killer T cells.
    Chung BK; Tsai K; Allan LL; Zheng DJ; Nie JC; Biggs CM; Hasan MR; Kozak FK; van den Elzen P; Priatel JJ; Tan R
    Blood; 2013 Oct; 122(15):2600-8. PubMed ID: 23974196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.